Protective Effect and Possible Mechanisms of Astragaloside IV in Animal Models of Diabetic Nephropathy: A Preclinical Systematic Review and Meta-Analysis

Frontiers in Pharmacology
Hong WangYi-Luan Wang

Abstract

Astragaloside IV (AS-IV) has a variety of biological activities and is widely used to treat kidney diseases. We conducted a systematic review of 24 animal studies including 424 animals to evaluate the efficacy of AS-IV for diabetic nephropathy (DN); all current possible mechanisms were summarized. A search strategy was applied to eight databases from inception to June 2020. The CAMARADES 10-item quality checklist and Rev-Man 5.3 software were used to analyze the risks of bias of each study and data regarding outcome measures, respectively. The mean study quality score was 5.4 points (range 3-8 points). Meta-analyses data and comparisons between groups showed that AS-IV significantly slowed the progression of pathological signs in the kidney including glomeruli and tubules, increasing creatinine clearance rate, decreasing blood urea nitrogen, serum creatinine, 24-h urinary neutrophil gelatinase-associated lipocalin and N-acetyl-β-D-glucosaminidase, 24-h urinary albumin, 24-h urinary microalbumin and HbA1c. There were no significant differences between experimental and control groups with respect to mortality or levels of alanine aminotransferase and aspartate aminotransferase. In terms of the possible mechanisms of treatment of ...Continue Reading

References

May 26, 1999·International Journal of Epidemiology·R J Hayes, S Bennett
May 9, 2003·American Journal of Physiology. Renal Physiology·Kumar SharmaStephen R Dunn
Apr 3, 2004·Stroke; a Journal of Cerebral Circulation·Malcolm R MacleodGeoffrey A Donnan
Dec 1, 2004·Basic & Clinical Pharmacology & Toxicology·Yongchuan GuJianguo Sun
May 24, 2006·European Journal of Drug Metabolism and Pharmacokinetics·C R HuangJ G Sun
Dec 15, 2010·American Journal of Physiology. Renal Physiology·G H Tesch, A K H Lim
Feb 26, 2011·Journal of Pharmacology & Pharmacotherapeutics·Carol KilkennyDouglas G Altman
Oct 17, 2012·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·UNKNOWN National Kidney Foundation
Jan 18, 2013·Apoptosis : an International Journal on Programmed Cell Death·Dingkun GuiNiansong Wang
Mar 29, 2014·BMC Medical Research Methodology·Carlijn R HooijmansMiranda W Langendam
May 8, 2014·Nature Reviews. Nephrology·Beatriz Fernandez-FernandezJesus Egido
Jul 2, 2014·Current Opinion in Endocrinology, Diabetes, and Obesity·Petter BjornstadDavid M Maahs
Jun 27, 2015·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Rajiv SaranKevin C Abbott
Sep 3, 2016·Scientific Reports·Huili SunShunmin Li
Mar 7, 2017·Nature Reviews. Nephrology·Allan Flyvbjerg
Apr 30, 2017·Diabetes Research and Clinical Practice·Dilip SharmaVinod Tiwari

❮ Previous
Next ❯

Methods Mentioned

BETA
transmission electron microscopy
light microscopy
MDA

Software Mentioned

ARRIVE
Photoshop
CAMARADES
RevMan

Related Concepts

Related Feeds

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms